Evidence map›Paper›PMID 24744022›Full record

ReviewCurrent neurology and neuroscience reports2014

Update on treatments for dystonia.

D Cristopher Bragg, Nutan Sharma

Abstract readReview
In one paragraph

Review in Current neurology and neuroscience reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

D Cristopher BraggDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Nutan Sharma
Massachusetts General Hospital · USMedical University of the Americas · KN

Funding

Torsin Function in DrosiphilaP50NS037409 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS · 2008 to 2013
$9.2M
TorsinA as a key link in receptor-mediated signalingP01NS087997 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI STANDAERT, DAVID G. · 2015 to 2019
$6.4M
NINDS NIH HHS P01 NS087997NINDS NIH HHS P50 NS037409NINDS NIH HHS P50NS037409
6 · The paper itself

Abstract

Oral medication, botulinum toxin injections, and deep brain stimulation are the current mainstays of treatment for dystonia. In addition, physical and other supportive therapies may help prevent further complications (eg, contractures) and improve function. This review discusses evidence-based medical treatment of dystonia with an emphasis on recent advances in treatment. We will also review the current treatment approaches and suggest ways in which these therapies can be applied to individuals with dystonia.

Indexed as

Anti-Dyskinesia AgentsDeep Brain StimulationDystoniaHumansPhysical Therapy ModalitiesRandomized Controlled Trials as TopicAnti-Dyskinesia Agents

Identifiers

PMID24744022
PMCPMC4477531
OpenAlexW2135352890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.